Posted on January 11, 2022
By Jennifer Snyder | Novartis Pharmaceuticals, Director, Portfolio Strategy Management for Technical Research and Development Cell & Gene Therapy
May 20, 2022
By Jason Rudd | Amgen, Statistical Programming Manager
The title of this article comes from an Amgen LinkedIn post I was featured in (https://www.linkedin.com/feed/update/urn:li:activity:6890409924724101120/), and I am grateful for the opportunity to expand on why I believe Amgen is a company that cares about people, and a company that listens. The photograph in the LinkedIn post, of me and my son both in […]
December 21, 2021
By Kaja Natland | Organon, Regional President, Asia Pacific & Japan
January 28, 2022
By Stuart Flanagan | Evotec, Group Leader
February 23, 2022
By Jürgen Schrapp | Bayer, Head of R&D Procurement
January 24, 2022
By Alexander M. Haydl | Boehringer Ingelheim Germany, Head of Late-Stage Development Laboratory and Product Owner of Digital Process Development
August 19, 2021
By Galym Dauletbakov | Takeda, Business Operations Head UCC
November 17, 2021
By Bo Quan Tan | Lonza Singapore, Manager of Project Engineering Department
March 7, 2022
By Vijetha Bhat | Lonza, Houston,Texas, Scientist, Research and Development
June 24, 2021
By Francis Van Parys | Cytiva, Vice President Commercial Asia Pacific
June 16, 2021
By Rajeev Nair | Merck, Senior Vice President & Head of Asia Pacific - Research Solutions
March 10, 2022
By Elizabeth Jurica | Bristol Myers Squibb, Principal Scientist
January 4, 2022
By Rebekah Martin | AstraZeneca, Senior Vice President of Reward and Inclusion
August 31, 2021
By Teresa Foy | Bristol Myers Squibb, Sr Vice President Immuno-Oncology and Cellular Therapy
